Current Advances of Liquid Biopsies in Prostate Cancer
Edwin M. Posadas, MD, FACP, explores prostate cancer diagnostics and treatment, emphasizing biomarkers and liquid biopsy technologies.
Read MoreSelect Page
Posted by Edwin M. Posadas, MD, FACP | Mar 2025
Edwin M. Posadas, MD, FACP, explores prostate cancer diagnostics and treatment, emphasizing biomarkers and liquid biopsy technologies.
Read MorePosted by Robert Dreicer, MD, MS, MACP, FASCO | Mar 2025
Robert Dreicer, MD, MS, MACP, FASCO, highlights the complexities of managing high-grade urothelial carcinoma of the upper tract.
Read MorePosted by Steven J. Frank, MD, FACR, FABS, FASTRO | Mar 2025
Steven J. Frank, MD, FACR, FABS, FASTRO, discusses advancements in MRI-assisted radiosurgery (MARS) for prostate cancer.
Read MorePosted by Daniel P. Petrylak, MD | Feb 2025
Daniel P. Petrylak, MD, analyzes bladder cancer treatment advancements, emphasizing recent clinical practice breakthroughs and challenges.
Read MorePosted by Nelson N. Stone, MD | Feb 2025
Nelson N. Stone, MD, balances the radiation dose and hormonal therapy in managing intermediate- and high-risk prostate cancer.
Read More